How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
Zaki IH, Shropshire E, Zhang S, Xiao D, Wildman-Tobriner B, Marin D, Gupta RT, Erkanli A, Nelson RC, Bashir MR.
Abdom Radiol (NY). 2021 Mar;46(3):969-978.

Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H, Song B, Qin Y, Chen J, Xiao D, Ha HI, Liu X, Oloruntoba-Sanders O, Erkanli A, Muir AJ, Bashir MR.
Eur Radiol. 2020 Nov 27.  (Online ahead of print)

Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, Babb JS, Chin X, Song J, Said D, Kihira S, Sirlin CB, Reeder SB, Bashir MR, Fowler KF, Ferket BS, Sigel K, Taouli B.
Eur Radiol. 2020 Nov;30(11):6003-6013.

LI-RADS ancillary feature prediction of longitudinal category changes in LR-3 observations: an exploratory study.
Shropshire E, Mamidipalli A, Wolfson T, Allen BC, Jaffe TA, Igarashi S, Higaki A, Tanabe M, Gamst A, Sirlin CB, Bashir MR.
Abdom Radiol (NY). 2020 Oct;45(10):3092-3102.

Imaging diamagnetic susceptibility of collagen in hepatic fibrosis using susceptibility tensor imaging.
Wei H, Decker K, Nguyen H, Cao S, Tsai TY, Dianne Guy C, Bashir M, Liu C.
Magn Reson Med. 2020 Apr;83(4):1322-1330.

The LI-RADS version 2018 MRI treatment response algorithm: Evaluation of ablated hepatocellular carcinoma.
Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB.
Radiology. 2020 Feb;294(2):320-326.

Deep convolutional neural network applied to the Liver Imaging Reporting and Data System (LI-RADS) version 2014 category classification: A pilot study.
Yamashita R, Mittendorf A, Zhu Z, Fowler KJ, Santillan CS, Sirlin CS, Bashir MR, Do RKG.
Abdom Radiol (NY). 2020 Jan;45(1):24-35.

Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI.
Nguyen KL, Yoshida T, Kathuria-Prakash N, Zaki IH, Varallyay CG, Semple SI, Saouaf R, Rigsby CK, Stoumpos S, Whitehead KK, Griffin LM, Saloner D, Hope MD, Prince MR, Fogel MA, Schiebler ML, Roditi GH, Radjenovic A, Newby DE, Neuwelt EA, Bashir MR, Hu P, Finn JP.
Radiology. 2019 Dec;293(3):554-564.

An update for LI-RADS: Version 2018. Why so soon after version 2017?
Kielar AZ, Chernyak V, Bashir MR, Do RK, Fowler KJ, Santillan C, Sirlin CB, Mitchell DG, Cerny M, Tang A, Elsayes KM, Kamaya A, Kono Y, Arora SS.
J Magn Reson Imaging. 2019 Dec;50(6):1990-1991.

User and system pitfalls in liver imaging with LI-RADS.
Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, Bashir MR, Furlan A, Sirlin CB.
J Magn Reson Imaging. 2019 Dec;50(6):1673-1686.

LI-RADS: Diagnostic performance of hepatobiliary phase hypointensity and major imaging features of LR-3 and LR-4 lesions measuring 10-19 mm with arterial phase hyperenhancement.
Vernuccio F, Cannella R, Meyer M, Choudhoury KR, Gonzales F, Schwartz FR, Gupta RT, Bashir MR, Furlan A, Marin D.
AJR Am J Roentgenol. 2019 Aug;213(2):W57-W65.

LI-RADS treatment response algorithm: performance and diagnostic accuracy.
Shropshire EL, Chaudhry M, Miller CM, Allen BC, Bozdogan E, Cardona DM, King LY, Janas GL, Do RK, Kim CY, Ronald J, Bashir MR.
Radiology. 2019 Jul;292(1):226-234.

Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.
Zulfiqar M, Sirlin CB, Yoneda N, Ronot M, Hecht EM, Chernyak V, Matsui O, Bastati N, Ba-Ssalamah A, Chatterjee D, Bashir M, Fowler KJ.
J Magn Reson Imaging. 2020 Jun;51(6):1630-1640.

Accuracy of the Liver Imaging Reporting and Data System in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy – a systematic review.
van der Pol CB, Lim CS, Sirlin CB, McGrath TA, Salameh JP, Bashir MR, Tang A, Singal AG, Costa AF, Fowler K, McInnes MD.
Gastroenterology. 2019 Mar;156(4):976-986.

LI-RADS: A conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.
Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodger SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB.
J Hepatocell Carcinoma. 2019 Feb 5;6:49-69.

Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients.
Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, Kono Y, Do RK, Mitchell DG, Singal AG, Tang A, Sirlin CB.
Radiology. 2018 Dec;289(3):816-830.

LI-RADS 2017: An Update.
Kielar A, Chernyak V, Bashir MR, Do RK, Fowler K, Mitchell D, Acerny M, Elsayes KM, Santillan C, Kono Y, Tang A, Sirlin C.
J Magn Reson Imaging. 2018 Jun;47(6)1459-1474.

Inter-reader reliability of LI-RADS v2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: A large international multi-reader study.
Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, Weinreb J, Hussain H, Mitchell DG, Bashir MR, Costa EAC, Cunha GM, Coombs L, Wolfson T, Gamst AC, Brancatelli G, Yeh B, Sirlin CB.
Radiology. 2018 Jan;286(1):173-185.

LI-RADS: A glimpse into the future.
Sirlin CB, Kielar AZ, Tang A, Bashir MR.
Abdom Radiol (NY). 2018 Jan;43(1):231-236.

Management implications and outcomes of LI- RADS-2, -3, -4, and -M category observations.
Mitchell DG, Bashir MR, Sirlin CB.
Abdom Radiol (NY). 2018 Jan:43(1):143-148.

Evidence supporting LI-RADS major features for CT- and MR Imaging-based diagnosis of heptocellular carcinoma: A systematic review.
Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG, Ehman EC, Fowler KJ, Hussain HK, Jha RC, Karam AR, Mamidipalli A, Marks RM, Mitchell DG, Morgan TA, Ohliger MA, Shah A, Vu KN, Sirlin CB; LI-RADS Evidence Working Group.
Radiology. 2018 Jan;286(1):29-48.

2017 Version of LI- RADS for CT and MR Imaging: An Update.
Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, Chernyak V, Bashir MR, Kono Y, Do RK, Mitchell DG, Hecht EM, Sirlin CB.
Radiographics. 2017 Nov- Dec;37(7):1994-2017.

Liver Imaging Reporting and Data System Category 4 Observations in MRI: Risk Factors Predicting Upgrade to Category 5.
Sofue K, Burke LM, Nilmini V, Alagiyawanna M, Muir AJ, Choudhury KR, Jaffe TA, Semelka RC, Bashir MR.
J Magn Reson Imaging. 2017 Sep;46(3):783-792.

Liver Imaging Reporting and Data System: An Expert Consensus Statement.
Elsayes KM, Kieler AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB.
J Hepatocell Carcinoma. 2017 Feb 17;4:29-39.

Natural history of Liver Imaging Reporting and Data System category 4 nodules in MRI.
Burke LMB, Sofue K, Alagiyawanna M, Nimini V, Muir AJ, Choudhury KR, Semelka RC, Bashir MR.
Abdom Radiol (NY). 2016 Sep;41(9):1758-66.

How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.
Sofue K, Sirlin CB, Allen BC, Nelson RC, Berg CL, Bashir MR.
J Magn Reson Imaging. 2016 Jun;43(6):1337-45.

Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
Bashir MR, Huang R, Mayes N, Marin D, Berg CL, Nelson RC, Jaffe TA.
J Magn Reson Imaging. 2015 Aug;42(2):305-14.

Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
Marks RM, Ryan A, Heba EH, Tang A, Wolfson TJ, Gamst AC, Sirlin CB, Bashir MR.
AJR Am J Roentgenol. 2015 Mar;204(3):527-535.

Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?
Bashir MR, Gupta RT, Davenport MS, Allen BC, Jaffe TA, Ho LM, Boll DT, Merkle EM.
J Magn Reson Imaging. 2013 Feb;37(2):398-406.